8,536 reports of this reaction
4.8% of all DIAZEPAM ORAL SOLUTION (CONCENTRATE) reports
#1 most reported adverse reaction
TOXICITY TO VARIOUS AGENTS is the #1 most commonly reported adverse reaction for DIAZEPAM ORAL SOLUTION (CONCENTRATE), manufactured by Alembic Pharmaceuticals Inc.. There are 8,536 FDA adverse event reports linking DIAZEPAM ORAL SOLUTION (CONCENTRATE) to TOXICITY TO VARIOUS AGENTS. This represents approximately 4.8% of all 177,526 adverse event reports for this drug.
Patients taking DIAZEPAM ORAL SOLUTION (CONCENTRATE) who experience toxicity to various agents should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TOXICITY TO VARIOUS AGENTS is moderately reported among DIAZEPAM ORAL SOLUTION (CONCENTRATE) users, representing a notable but not dominant share of adverse events.
In addition to toxicity to various agents, the following adverse reactions have been reported for DIAZEPAM ORAL SOLUTION (CONCENTRATE):
The following drugs have also been linked to toxicity to various agents in FDA adverse event reports:
TOXICITY TO VARIOUS AGENTS has been reported as an adverse event in 8,536 FDA reports for DIAZEPAM ORAL SOLUTION (CONCENTRATE). This does not prove causation, but indicates an association observed in post-market surveillance data.
TOXICITY TO VARIOUS AGENTS accounts for approximately 4.8% of all adverse event reports for DIAZEPAM ORAL SOLUTION (CONCENTRATE), making it one of the most commonly reported side effect.
If you experience toxicity to various agents while taking DIAZEPAM ORAL SOLUTION (CONCENTRATE), contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.